亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial☆

医学 奥沙利铂 放化疗 危险系数 癌症 内科学 胃切除术 结直肠癌 临床终点 随机化 化疗 随机对照试验 肿瘤科 胃肠病学 外科 置信区间
作者
S.H. Park,D.H. Lim,Tae Sung Sohn,J. Lee,Dae Young Zang,S.T. Kim,Jung Hun Kang,Sung Yong Oh,In Gyu Hwang,Jun Ho Ji,D.B. Shin,Jeong Il Yu,K.-M. Kim,Ji Yeong An,M.G. Choi,J.H. Lee,S. Kim,Jung Yong Hong,Joon Oh Park,Y.S. Park
出处
期刊:Annals of Oncology [Elsevier BV]
卷期号:32 (3): 368-374 被引量:232
标识
DOI:10.1016/j.annonc.2020.11.017
摘要

Adjuvant chemotherapy and chemoradiotherapy are some of the standards of care for gastric cancer (GC). The Adjuvant chemoRadioTherapy In Stomach Tumors (ARTIST) 2 trial compares two adjuvant chemotherapy regimens and chemoradiotherapy in patients with D2-resected, stage II or III, node-positive GC.The ARTIST 2 compared, in a 1:1:1 ratio, three adjuvant regimens: oral S-1 (40-60 mg twice daily 4 weeks on/2 weeks off) for 1 year, S-1 (2 weeks on/1 week off) plus oxaliplatin 130 mg/m2 every 3 weeks (SOX) for 6 months, and SOX plus chemoradiotherapy 45 Gy (SOXRT). Randomization was stratified according to surgery type (total or subtotal gastrectomy), pathologic stage (II or III), and Lauren histologic classification (diffuse or intestinal/mixed). The primary endpoint was disease-free survival (DFS) at 3 years; a reduction of 33% in the hazard ratio (HR) for DFS with SOX or SOXRT, when compared with S-1, was considered clinically meaningful. The trial is registered at clinicaltrials.gov (NCT0176146).A total of 546 patients were recruited between February 2013 and January 2018 with 182, 181, and 183 patients in the S-1, SOX, and SOXRT arms, respectively. Median follow-up period was 47 months, with 178 DFS events observed. Estimated 3-year DFS rates were 64.8%, 74.3%, and 72.8% in the S-1, SOX, and SOXRT arms, respectively. HR for DFS in the control arm (S-1) was shorter than that in the SOX and SOXRT arms: S-1 versus SOX, 0.692 (P = 0.042) and S-1 versus SOXRT, 0.724 (P = 0.074). No difference in DFS was found between SOX and SOXRT (HR 0.971; P = 0.879). Adverse events were as anticipated in each arm, and were generally well-tolerated and manageable.In patients with curatively D2-resected, stage II/III, node-positive GC, adjuvant SOX or SOXRT was effective in prolonging DFS, when compared with S-1 monotherapy. The addition of radiotherapy to SOX did not significantly reduce the rate of recurrence after D2 gastrectomy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
苹果紫发布了新的文献求助10
12秒前
19秒前
wuran发布了新的文献求助10
25秒前
29秒前
番茄发布了新的文献求助10
36秒前
wuran发布了新的文献求助10
56秒前
1分钟前
鬼见愁完成签到,获得积分0
1分钟前
赘婿应助wuran采纳,获得10
1分钟前
Benhnhk21完成签到,获得积分10
1分钟前
苹果紫发布了新的文献求助10
1分钟前
1分钟前
2分钟前
2分钟前
CAOHOU应助Benhnhk21采纳,获得10
2分钟前
2分钟前
大熊完成签到,获得积分20
2分钟前
大熊发布了新的文献求助10
2分钟前
wuran发布了新的文献求助10
2分钟前
烟花应助MA采纳,获得10
2分钟前
番茄发布了新的文献求助10
2分钟前
田様应助wuran采纳,获得10
3分钟前
苹果紫发布了新的文献求助10
3分钟前
3分钟前
3分钟前
wuran发布了新的文献求助10
3分钟前
4分钟前
852应助wuran采纳,获得10
4分钟前
23应助科研通管家采纳,获得10
4分钟前
4分钟前
Qvby3完成签到 ,获得积分10
4分钟前
魔镜魔镜告诉我有病完成签到,获得积分10
4分钟前
wuran发布了新的文献求助10
4分钟前
4分钟前
4分钟前
哇呀呀完成签到 ,获得积分10
4分钟前
大个应助无风采纳,获得10
4分钟前
欢喜板凳完成签到 ,获得积分0
4分钟前
Bugs完成签到,获得积分10
4分钟前
dx完成签到,获得积分10
5分钟前
高分求助中
Semantics for Latin: An Introduction 1055
Plutonium Handbook 1000
Three plays : drama 1000
International Code of Nomenclature for algae, fungi, and plants (Madrid Code) (Regnum Vegetabile) 1000
Psychology Applied to Teaching 14th Edition 600
Robot-supported joining of reinforcement textiles with one-sided sewing heads 600
Apiaceae Himalayenses. 2 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4099084
求助须知:如何正确求助?哪些是违规求助? 3636653
关于积分的说明 11525719
捐赠科研通 3346409
什么是DOI,文献DOI怎么找? 1839241
邀请新用户注册赠送积分活动 906499
科研通“疑难数据库(出版商)”最低求助积分说明 823819